Synopsis:
Physicians are still reluctant to use β-blockers in COPD patients as it is a contraindication. Previous studies evaluating pulmonary function test showed that β-blockers could be used in patients with COPD. The aim of this study is to evaluate the effect of cardioselective β-blockers on cardiopulmonary capacity during exercise. A novel test, CPET, is used in our study.